CCCCn1c(-c2ccc(Br)cc2F)nc2c1c(=O)[nH]c(=O)n2CC(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?